Genomic mutations and histopathologic biomarkers in Y radioembolization for chemorefractory colorectal liver metastases

about

Genomic mutations and histopathologic biomarkers in Y radioembolization for chemorefractory colorectal liver metastases

Item

http://www.wikidata.org/entity/Q58727444

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Genomic mutations and histopat ...... ry colorectal liver metastases

@en

Genomic mutations and histopat ...... ry colorectal liver metastases

@nl

type

Item

label

Genomic mutations and histopat ...... ry colorectal liver metastases

@en

Genomic mutations and histopat ...... ry colorectal liver metastases

@nl

prefLabel

Genomic mutations and histopat ...... ry colorectal liver metastases

@en

Genomic mutations and histopat ...... ry colorectal liver metastases

@nl

P1476

Genomic mutations and histopat ...... ry colorectal liver metastases

@en

P2093

Howard S Hochster

http://www.w3.org/2001/XMLSchema#string

Hyun S Kim

http://www.w3.org/2001/XMLSchema#string

Jill Lacy

http://www.w3.org/2001/XMLSchema#string

Johannes M Ludwig

http://www.w3.org/2001/XMLSchema#string

Meaghan S Dendy

http://www.w3.org/2001/XMLSchema#string

Nima Kokabi

http://www.w3.org/2001/XMLSchema#string

Stacey M Stein

http://www.w3.org/2001/XMLSchema#string

P2860

The Cancer Genome Atlas Pan-Cancer analysis project

Cancer treatment and survivorship statistics, 2012

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis

Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies.

Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy.

Stereotactic body radiation therapy for colorectal liver metastases.

Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.

P304

32523-32533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25992

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30197760

http://www.w3.org/2001/XMLSchema#string

P932

6126695

http://www.w3.org/2001/XMLSchema#string